# Japanese BAY80-6946 Monotherapy Phase I Study

> **NCT01404390** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 10 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** BAY80-6946
- **DRUG:** BAY80-6946

## Key facts

- **NCT ID:** NCT01404390
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08-18
- **Primary completion:** 2012-03-22
- **Final completion:** 2012-07-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01404390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01404390, "Japanese BAY80-6946 Monotherapy Phase I Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01404390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*